Henry Kerner

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Colts QB Richardson's injury raises durability concerns as analysts criticize his decision-making.
  • Intel CEO faces resignation calls over alleged China ties, raising national security concerns.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Colts QB Richardson's injury raises durability concerns as analysts criticize his decision-making.
  • Intel CEO faces resignation calls over alleged China ties, raising national security concerns.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Henry Kerner